| Generous friends like you are the reason we are Making Cancer History®.
Our new fiscal year is underway at The University of Texas MD Anderson Cancer Center, and with it I would like to share the news of our new Senior Vice President and Chief Development Officer, Darrow Zeidenstein, Ph.D. Motivated by his loss of close family members to cancer, Dr. Zeidenstein is committed to bringing us closer to the day we end cancer.
Of course, thanks to dedicated donors like you, there are more lifesaving breakthroughs than ever on the horizon.
Right now, our scientists are conducting more than 1,250 clinical trials to advance promising new treatments for patients, including:
| • | New small-cell molecule therapies that target solid tumors
| | • | Antibodies that kill leukemia cells
| | • | Immunotherapies with the potential to treat previously untreatable cancers |
|
You help make it possible. Together, we can continue to turn the latest discoveries into clinical advances that can reduce the devastating effects of cancer — and save lives.
On behalf of all of us at MD Anderson and people around the world facing cancer, thank you.
| Sincerely,
Peter WT Pisters, M.D.
President
|
| 